Progress in Skin Cancer Research
Seiten
2007
Nova Science Publishers Inc (Verlag)
978-1-60021-095-2 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-60021-095-2 (ISBN)
Three types of skin cancer account for nearly 100 per cent of all diagnosed cases. Each of these three cancers begins in a different type of cell within the skin, and each cancer is named for the type of cell in which it begins: Basal cell carcinoma (BCC); Squamous cell carcinoma (SCC); and Melanoma. This book examines the research in this field.
Three types of skin cancer account for nearly 100% of all diagnosed cases. Each of these three cancers begins in a different type of cell within the skin, and each cancer is named for the type of cell in which it begins. Skin cancers are divided into one of two classes -- non-melanoma skin cancers and melanoma. Melanoma is the deadliest form of skin cancer. The different types of skin cancer are: Basal cell carcinoma (BCC); Squamous cell carcinoma (SCC); Melanoma. All other skin cancers combined account for less than 1% of diagnosed cases. These are classified as non-melanoma skin cancers and include Merkel cell carcinoma, dermatofibromasarcoma protuberans, Paget's disease and cutaneous T-cell lymphoma. This book examines the latest research in this field.
Three types of skin cancer account for nearly 100% of all diagnosed cases. Each of these three cancers begins in a different type of cell within the skin, and each cancer is named for the type of cell in which it begins. Skin cancers are divided into one of two classes -- non-melanoma skin cancers and melanoma. Melanoma is the deadliest form of skin cancer. The different types of skin cancer are: Basal cell carcinoma (BCC); Squamous cell carcinoma (SCC); Melanoma. All other skin cancers combined account for less than 1% of diagnosed cases. These are classified as non-melanoma skin cancers and include Merkel cell carcinoma, dermatofibromasarcoma protuberans, Paget's disease and cutaneous T-cell lymphoma. This book examines the latest research in this field.
Preface; Novel Therapeutic Strategy for the Treatment of Malignant Melanoma; Childhood Melanoma; The Incidence of Melanocytic Naevi (Moles) in Young Children; Sentinel Lymph Node Biopsy in Clinically Node-Negative Patients with Cutaneous Melanoma: Prognostic and Therapeutic Implications; Preliminary Results of a Melanoma Referral Centre on the Trends in Malignant Melanoma in Turkey; Cell Adhesion Molecule Expression in Melanoma Progression: The Staging System of the Future?; Biopsy of Sentinel Lymph Nodes in the Malignant Melanoma of the Skin; Radiation and Non-Melanoma Skin Cancers; Targeted Therapy in Treatment of Melanoma; Index.
| Erscheint lt. Verlag | 10.5.2007 |
|---|---|
| Zusatzinfo | Illustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 260 x 180 mm |
| Gewicht | 600 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| ISBN-10 | 1-60021-095-3 / 1600210953 |
| ISBN-13 | 978-1-60021-095-2 / 9781600210952 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Differentialdiagnostik und Therapie bei Kindern und Jugendlichen
Buch (2022)
Thieme (Verlag)
CHF 191,00
Allergene - Diagnostik - Therapie
Buch (2022)
Thieme (Verlag)
CHF 249,00
richtig verschreiben – individuell therapieren
Buch (2023)
Thieme (Verlag)
CHF 99,40
